- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05014503
A Computerized, Adaptive Therapeutic Gaming Approach Training Visual Perceptual Skills in Children with CVI (iVision2_WP3)
A Randomized Controlled Trial to Evaluate the Effectiveness of a Computerized, Adaptive Therapy Approach for Children with Cerebral Visual Impairment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cerebral Visual Impairment (CVI) is the most common cause of visual disability in developed countries (one to two cases per 1000 live births). A person with CVI usually has normal eye function but processing visual information in the brain is hindered. This results in a complex variation of symptoms, ranging from problems with object and shape recognition over problems with figure ground and cluttered scenes to deficits in spatial navigation. Each child with CVI presents with a nearly unique visual perceptual profile, due to the varying nature of the underlying damage and the appearance of age related deficits. In a previous project, we developed a method to quantify the visual profile of children with CVI, enabling more individualized and targeted therapy. The researchers developed an adaptive, personalized gamified visual perceptual therapy program for children with CVI, based on this quantified visual profile, with the aim to apply a targeted, individualized approach that strengthens motivation and thereby increases effectiveness.
This clinical trial aims to compare the effectiveness of our adaptive, therapeutic game to the effectiveness of the same game, without the adaptive component. In the adaptive game, the game entry level is adapted to the visual perceptual capacities of the child, as defined by the visual perceptual profile. In addition, the difficulty level of the adaptive game will adapt itself to the gaming results and behaviour of the child. The non-adaptive version of the game consists of the same set of mini-games, but the entry-level is the same for all children (basic or 0 entry-level) and gradually increased, independent of the gaming results, success and behaviour of the child.
The researchers will use a double-blind, randomized controlled trial design, including children with a developmental age between 3 and 12years old, a diagnosis of CVI, acuity >0.2, with sufficient manual coordination to control a mouse, keypad or touch screen. All children will use the gamified therapy program for three months, with a minimum of three times per week, 15- 20 minutes. The software will be installed on a personal device of choice by the child and/or its parents. Children willing to participate, but not having a personal device, will receive a tablet computer from the researchers during the intervention period. A blinded evaluator will evaluate the effectiveness on the main components of the visual perceptual profile of the child (primary outcome), on eye tracking parameters, functional vision and quality of life, at the end and at three months follow-up. Enjoyment and user experience will be monitored closely during the intervention period. As usual and regular therapy of the children will not be influenced during the intervention period, we will ask the parents and/or caretaker to register all other relevant gaming and therapy activities performed during that period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vlaams-brabant
-
Leuven, Vlaams-brabant, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Voluntary written informed consent of the participant or their legally authorized representative
- A confirmed diagnosis of CVI
- Dutch-speaking
- A developmental age between 3 and 12 years.
- Sufficient motor abilities (cerebral palsy with a Gross Motor Function Classification level <V)
- Sufficient fine motor function to handle a tablet or laptop (Manual Ability Classification System level <4)
- Able to express their experiences with the game.
- A visual acuity of more than 0.2 (Snellen notation)
Exclusion Criteria:
- Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol
- Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial
- Children not speaking or understanding Dutch language
- Children with limited gross motor function abilities (GMFCS V)
- Children with limited hand function (MACS 4-5)
- Children unable to express their experiences with the game due to serious speech disorders, deafness or autism.
- A visual acuity of less than 0.2 (Snellen notation)
- Serious behavioural problems limiting participation to the games
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adaptive version of the therapeutic game
The adaptive therapeutic game will use a game-entry level that is based on the individual visual perceptual profile of the child.
Children with higher visual perceptual capacities will be able to start the game at a higher entry level compared to children with lower visual perceptual capacities.
Thereby, the entry level will also be different for the different games.
In addition, the adaptive game uses an in-game adaptivity system that has been developed using artificial intelligence (more specifically, reinforcement learning): this means that the game can adjust the difficulty automatically, based on the game-behaviour and success of the child.
Children learning fast, will more quickly move to higher difficulty levels compared to children learning slower.
Thereby, this in-game adaptivity also enables children to return to lower difficulty levels when a difficulty level is too high.
|
All children will be asked to use the adaptive version of the therapeutic game for three months, during their free time, at home or at the special school where they stay.
They will be asked to play the game minimally three times per week between 20-30 minutes per session.
The researchers will install the game on a device of choice for the children.
Back-up devices are available from the study team to ensure that children having no suitable device can participate in the study.
The parent and/or caretaker will be asked to support the child in starting the program, but not to intervene during the actual game time.
The game is designed to ensure that children can play independently.
Therefore, children will be able to play at home, at school or during their free time.
The program will not replace their regular therapy program, but will be provided additionally.
The number of regular therapy hours will however be registered.
|
|
Active Comparator: Non-adaptive version of the therapeutic game
The non-adaptive therapeutic game will use the same, lowest entry level for all children.
During game play, a fixed stepwise increase in difficulty will be built in, not adjusted to the gaming behaviour or success of the child.
All children will follow the same, gradual approach in difficulty and a fixed number of trials is set for each difficulty level.
To prevent extreme frustration however, a safety margin is integrated by preventing the difficulty level to increase further when a child has more than a predefined number of unsuccessful trials.
Likewise, the stepwise increase in difficulty level will only continue after a fixed, predefined number of successful trials.
A child will also never return to a lower difficulty level, once a difficulty level is reached.
|
All children will be asked to use the non-adaptive version of the therapeutic game for three months, during their free time, at home or at the special school where they stay.
They will be asked to play the game minimally three times per week between 20-30 minutes per session.
The researchers will install the game on a device of choice for the children.
Back-up devices are available from the study team to ensure that children having no suitable device can participate in the study.
The parent and/or caretaker will be asked to support the child in starting the program, but not to intervene during the actual game time.
The game is designed to ensure that children can play independently.
Therefore, children will be able to play at home, at school or during their free time.
The program will not replace their regular therapy program, but will be provided additionally.
The number of regular therapy hours will however be registered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Perceptual Profile
Time Frame: pre-intervention (Day 0)
|
Quantified visual profile as described by Ben Itzhak et al. (2021): at individual (most deviant z-score) and general level (overall visual perceptual capacity in a composite score)
|
pre-intervention (Day 0)
|
|
Visual Perceptual Profile
Time Frame: immediately post-intervention (after 3 months of training)
|
Quantified visual profile as described by Ben Itzhak et al. (2021): at individual (most deviant z-score) and general level (overall visual perceptual capacity in a composite score)
|
immediately post-intervention (after 3 months of training)
|
|
Visual Perceptual Profile
Time Frame: at 3 months follow-up (after 6 months)
|
Quantified visual profile as described by Ben Itzhak et al. (2021): at individual (most deviant z-score) and general level (overall visual perceptual capacity in a composite score)
|
at 3 months follow-up (after 6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Perceptual Tests (individual test scores) (younger children, age 3-6y)
Time Frame: pre-intervention (at day 0)
|
- L94 Visual Perceptual Battery: object recognition battery which evaluates (degraded) object recognition, figured-ground, motion perception and global-local processing (Ortibus et al., 2015).
|
pre-intervention (at day 0)
|
|
Visual Perceptual Tests (individual test scores) (younger children, dev age 3-6y)
Time Frame: immediately post-intervention (after 3 months)
|
- L94 Visual Perceptual Battery: object recognition battery which evaluates (degraded) object recognition, figured-ground, motion perception and global-local processing (Ortibus et al., 2015).
|
immediately post-intervention (after 3 months)
|
|
Visual Perceptual Tests (individual test scores) (younger children, age 3-6y)
Time Frame: at 3 months follow-up (after 6 months)
|
- L94 Visual Perceptual Battery: object recognition battery which evaluates (degraded) object recognition, figured-ground, motion perception and global-local processing (Ortibus et al., 2015).
|
at 3 months follow-up (after 6 months)
|
|
Visual Perceptual Tests (individual test scores) (older children, age 6-12y)
Time Frame: pre-intervention (at day 0)
|
- Test of Visual Perceptual Skills-3 (TVPS-3): includes subtasks of visual discrimination, visual memory, visual-spatial relationships, form constancy, visual sequential memory, figure ground, and visual closure (Martin et al., 2006).
|
pre-intervention (at day 0)
|
|
Visual Perceptual Tests (individual test scores) (older children, aged 6-12y)
Time Frame: immediately post-intervention (after 3 months)
|
- Test of Visual Perceptual Skills-3 (TVPS-3): includes subtasks of visual discrimination, visual memory, visual-spatial relationships, form constancy, visual sequential memory, figure ground, and visual closure (Martin et al., 2006).
|
immediately post-intervention (after 3 months)
|
|
Visual Perceptual Tests (individual test scores) (older children, aged 6-12y)
Time Frame: at 3 months follow-up (after 6 months)
|
- Test of Visual Perceptual Skills-3 (TVPS-3): includes subtasks of visual discrimination, visual memory, visual-spatial relationships, form constancy, visual sequential memory, figure ground, and visual closure (Martin et al., 2006).
|
at 3 months follow-up (after 6 months)
|
|
Eye-tracking
Time Frame: pre-intervention (at day 0)
|
eye-movements using eye-tracking
|
pre-intervention (at day 0)
|
|
Eye-tracking
Time Frame: immediately post-intervention (after 3 months)
|
eye-movements using eye-tracking
|
immediately post-intervention (after 3 months)
|
|
Eye-tracking
Time Frame: at 3 months follow-up (after 6 months)
|
eye-movements using eye-tracking
|
at 3 months follow-up (after 6 months)
|
|
Daily functioning questionnaires
Time Frame: pre-intervention (at day 0)
|
Questionnaires evaluating daily functioning: Insight Question Inventory, (IQI), Pediatric Quality of Life Inventory (PedsQL), the Flemish cerebral visual impairment questionnaire (FCVIQ).
|
pre-intervention (at day 0)
|
|
Daily functioning questionnaires
Time Frame: immediately post-intervention (after 3 months)
|
Questionnaires evaluating daily functioning: Insight Question Inventory, (IQI), Pediatric Quality of Life Inventory (PedsQL), the Flemish cerebral visual impairment questionnaire (FCVIQ).
|
immediately post-intervention (after 3 months)
|
|
Daily functioning questionnaires
Time Frame: at 3 months follow-up (after 6 months)
|
Questionnaires evaluating daily functioning: Insight Question Inventory, (IQI), Pediatric Quality of Life Inventory (PedsQL), the Flemish cerebral visual impairment questionnaire (FCVIQ).
|
at 3 months follow-up (after 6 months)
|
|
Functional evaluation of visual perception
Time Frame: pre-intervention (at day 0)
|
Change in an adapted Virtual Toybox (Bauer et al., 2008)
|
pre-intervention (at day 0)
|
|
Functional evaluation of visual perception
Time Frame: immediately post-intervention (after 3 months)
|
Adapted Virtual Toybox (Bauer et al., 2008)
|
immediately post-intervention (after 3 months)
|
|
Functional evaluation of visual perception
Time Frame: at 3 months follow-up (after 6 months)
|
Adapted Virtual Toybox (Bauer et al., 2008)
|
at 3 months follow-up (after 6 months)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Els Ortibus, MD PhD, UZ Leuven / KU Leuven
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- s65773
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Visual Impairment
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; University Ghent; Research Foundation Flanders; Free University of Brussels and other collaboratorsUnknowniVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment (iVision)Visual Perceptual Weakness (Disorder) | Cerebral Visual ImpairmentBelgium
-
National Taiwan University HospitalRecruitingCerebral Visual Impairment | Visual Rehabilitation | Oddball Design | Passive Visual Stimulation | Perceptual LearningTaiwan
-
Kahramanmaras Sutcu Imam UniversityCompletedCerebral Palsy | Visual Impairment | Cerebral Palsy, Spastic | Cerebral Visual Impairment | Visual DisorderTurkey
-
Trakya UniversityCompletedFeeding Behavior | Cerebral Visual Impairment | Sensory Integration DisorderTurkey
-
Rockhurst UniversityRecruitingCerebral Palsy | Cortical/Cerebral Visual ImpairmentUnited States
-
Penn State UniversityCompletedCerebral Palsy | Cortical Visual ImpairmentUnited States
-
Sheba Medical CenterCompletedCerebral Palsy | Cortical Visual ImpairmentIsrael
-
Children's Hospital Medical Center, CincinnatiNational Eye Institute (NEI)Enrolling by invitationCerebral Visual ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedNeovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNVGermany
-
Russell L. WoodsResearch to Prevent Blindness / Lions Club International FoundationNot yet recruitingCentral Visual Impairment
Clinical Trials on Adaptive Therapeutic gaming
-
Cairo UniversityNot yet recruiting
-
Children's Hospital of Eastern OntarioCanadian Institutes of Health Research (CIHR)CompletedActive Video Games and Appetite ControlCanada
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of British ColumbiaTerminatedStroke | Stroke, Ischemic | Stroke Hemorrhagic | Stroke, LacunarCanada
-
Cairo UniversityRecruiting
-
New York Institute of TechnologyCompletedCognitive Performance in Healthy VolunteersUnited States
-
Riphah International UniversityCompleted
-
University of OuluCompletedAging | Depressive Symptoms | Sedentary Behavior | Loneliness | Physical Inactivity | Social IsolationFinland
-
East Tennessee State UniversityWithdrawnAnxiety | Biofeedback, Psychology
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada